All
Results: 34369-34380 of 70864

Juniper Research: Conversational AI to Generate $57 Billion of Revenue Globally Over Next Three Years

Galderma’s Nemluvio® (Nemolizumab) Granted Marketing Authorization in the United Kingdom and Switzerland for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis








